BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, Lerner SP, Löhe F, Louhimo J, Sawczuk I, Taketa K, Diamandis EP; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010;56:e1-48. [PMID: 20207771 DOI: 10.1373/clinchem.2009.133124] [Cited by in Crossref: 146] [Cited by in F6Publishing: 119] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Charakorn C, Thadanipon K, Chaijindaratana S, Rattanasiri S, Numthavaj P, Thakkinstian A. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis. Gynecologic Oncology 2018;150:190-200. [DOI: 10.1016/j.ygyno.2018.03.056] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
2 Chen P, Jiao L, Ren F, Wang DB. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma. BMC Cancer 2020;20:423. [PMID: 32410650 DOI: 10.1186/s12885-020-06934-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study. PLoS One 2015;10:e0122361. [PMID: 25860888 DOI: 10.1371/journal.pone.0122361] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
4 Lin JP, Lin JX, Ma YB, Xie JW, Yan S, Wang JB, Lu J, Chen QY, Ma XF, Cao LL, Lin M, Tu RH, Zheng CH, Li P, Huang CM. Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer. Br J Cancer 2020;123:418-25. [PMID: 32451469 DOI: 10.1038/s41416-020-0901-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
5 Hou C, Tan G, Feng S. Clinical significance of microRNA expressions in diagnosing uterine cancer and predicting lymph node metastasis. Tumour Biol 2014;35:10789-98. [PMID: 25077926 DOI: 10.1007/s13277-014-2382-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
6 Ye F, Zhao Y, El-sayed R, Muhammed M, Hassan M. Advances in nanotechnology for cancer biomarkers. Nano Today 2018;18:103-23. [DOI: 10.1016/j.nantod.2017.12.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 12.3] [Reference Citation Analysis]
7 Duffy MJ. Tumor markers in clinical practice: a review focusing on common solid cancers. Med Princ Pract. 2013;22:4-11. [PMID: 22584792 DOI: 10.1159/000338393] [Cited by in Crossref: 114] [Cited by in F6Publishing: 89] [Article Influence: 12.7] [Reference Citation Analysis]
8 Kim M, Oh B, Kim TY, Yoon SS, Kim SY, Hwang SM, Lee DS. Elevated telomerase activity in essential thrombocythemia with extreme thrombocytosis. Clin Biochem 2014;47:389-92. [PMID: 24440836 DOI: 10.1016/j.clinbiochem.2014.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Qi F, Liu Y, Zhao R, Zou X, Zhang L, Li J, Wang Y, Li F, Zou X, Xia Y, Wang X, Xing L, Li C, Lu J, Tang J, Zhou F, Liu C, Gui Y, Cai Z, Sun X. Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance. Tumour Biol 2014;35:7217-23. [PMID: 24771263 DOI: 10.1007/s13277-014-1894-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
10 Tai CJ, Liao CF, Su TC, Shen KH, Chang CC, Lin SH, Yeh CM, Shen SC, Lee WR, Chiou JF, Lin CH, Chen YC, Shih HY, Yeh KT, Jiang MC. Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas. Int J Biol Markers 2012;27:e280-4. [PMID: 22653741 DOI: 10.5301/JBM.2012.9310] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
11 Schmitt M, Harbeck N, Brünner N, Jänicke F, Meisner C, Mühlenweg B, Jansen H, Dorn J, Nitz U, Kantelhardt EJ. Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Rev Mol Diagn. 2011;11:617-634. [PMID: 21745015 DOI: 10.1586/erm.11.47] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
12 Guo L, Wang Q, Chen K, Liu HP, Chen X. Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer. J Gastrointest Surg 2021. [PMID: 33575904 DOI: 10.1007/s11605-021-04944-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li J, Zhou Y, Wang X, Yu Y, Zhou X, Luan K. Histogram Analysis of Diffusion-Weighted Magnetic Resonance Imaging as a Biomarker to Predict Lymph Node Metastasis in T3 Stage Rectal Carcinoma. Cancer Manag Res 2021;13:2983-93. [PMID: 33833581 DOI: 10.2147/CMAR.S298907] [Reference Citation Analysis]
14 Sölétormos G, Duffy MJ, Hayes DF, Sturgeon CM, Barak V, Bossuyt PM, Diamandis EP, Gion M, Hyltoft-Petersen P, Lamerz RM, Nielsen DL, Sibley P, Tholander B, Tuxen MK, Bonfrer JM. Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor Markers. Clin Chem 2013;59:52-9. [PMID: 23034139 DOI: 10.1373/clinchem.2011.180778] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
15 Shimura T, Dayde D, Wang H, Okuda Y, Iwasaki H, Ebi M, Kitagawa M, Yamada T, Yamada T, Hanash SM, Taguchi A, Kataoka H. Novel urinary protein biomarker panel for early diagnosis of gastric cancer. Br J Cancer 2020;123:1656-64. [PMID: 32934343 DOI: 10.1038/s41416-020-01063-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
16 Wan QS, Zhang KH. Noninvasive detection of gastric cancer. Tumour Biol. 2016;37:11633-11643. [PMID: 27381515 DOI: 10.1007/s13277-016-5129-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kim SH, Won KS, Choi BW, Jo I, Zeon SK, Chung WJ, Kwon JH. Usefulness of F-18 FDG PET/CT in the Evaluation of Early Treatment Response After Interventional Therapy for Hepatocellular Carcinoma. Nucl Med Mol Imaging. 2012;46:102-110. [PMID: 24900042 DOI: 10.1007/s13139-012-0138-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
18 Lin G, Liu T, Zou L, Hou J, Wu Y. Development of a dual-label time-resolved fluoroimmunoassay for the detection of α-fetoprotein and hepatitis B virus surface antigen: Fluoroimmunoassay for the detection of α-fetoprotein and hepatitis B virus surface antigen. Luminescence 2013;28:401-6. [DOI: 10.1002/bio.2396] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
19 Jiang Y, He J, Li Y, Guo Y, Tao H. The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis. Biomed Res Int 2019;2019:5179048. [PMID: 31871941 DOI: 10.1155/2019/5179048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mao X, Guo Y, Lu Z, Wen F, Liang H, Sun W. Enhanced CT Textures Derived From Computer Mathematic Distribution Analysis Enables Arterial Enhancement Fraction Being an Imaging Biomarker Option of Hepatocellular Carcinoma. Front Oncol 2020;10:1337. [PMID: 32850426 DOI: 10.3389/fonc.2020.01337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hermann N, Dreßen K, Schildberg FA, Jakobs C, Holdenrieder S. Methodical and pre-analytical characteristics of a multiplex cancer biomarker immunoassay. World J Methodol 2014; 4(4): 219-231 [PMID: 25541602 DOI: 10.5662/wjm.v4.i4.219] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
22 Diamandis EP. Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst 2010;102:1462-7. [PMID: 20705936 DOI: 10.1093/jnci/djq306] [Cited by in Crossref: 260] [Cited by in F6Publishing: 216] [Article Influence: 23.6] [Reference Citation Analysis]
23 Don-wauchope AC, Sievenpiper JL, Hill SA, Iorio A. Applicability of the AGREE II Instrument in Evaluating the Development Process and Quality of Current National Academy of Clinical Biochemistry Guidelines. Clinical Chemistry 2012;58:1426-37. [DOI: 10.1373/clinchem.2012.185850] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
24 Liu C, Zeng H, Zhao J, Rong Y, Mo Z, Li LA, Zhang J. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix: . International Journal of Gynecological Cancer 2017;27:994-1000. [DOI: 10.1097/igc.0000000000000990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Torres C, Grippo PJ. Pancreatic cancer subtypes: a roadmap for precision medicine. Ann Med 2018;50:277-87. [PMID: 29537309 DOI: 10.1080/07853890.2018.1453168] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
26 Chen H, Tian L, Chen J, Sun P, Han R, Wu X, Dai S. Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma. Cancer Control 2020;27:1073274820983025. [PMID: 33356502 DOI: 10.1177/1073274820983025] [Reference Citation Analysis]
27 Lario S, Brunet-Vega A, Quílez ME, Ramírez-Lázaro MJ, Lozano JJ, García-Martínez L, Pericay C, Miquel M, Junquera F, Campo R, Calvet X. Expression profile of circulating microRNAs in the Correa pathway of progression to gastric cancer. United European Gastroenterol J 2018;6:691-701. [PMID: 30083331 DOI: 10.1177/2050640618759433] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
28 Armero VES, Tremblay MP, Allaire A, Boudreault S, Martenon-Brodeur C, Duval C, Durand M, Lapointe E, Thibault P, Tremblay-Létourneau M, Perreault JP, Scott MS, Bisaillon M. Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas. PLoS One 2017;12:e0176880. [PMID: 28493890 DOI: 10.1371/journal.pone.0176880] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
29 Alaiyan B, Ilyayev N, Stojadinovic A, Izadjoo M, Roistacher M, Pavlov V, Tzivin V, Halle D, Pan H, Trink B, Gure AO, Nissan A. Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence. BMC Cancer 2013;13:196. [PMID: 23594791 DOI: 10.1186/1471-2407-13-196] [Cited by in Crossref: 93] [Cited by in F6Publishing: 95] [Article Influence: 11.6] [Reference Citation Analysis]
30 Liu T, Hossain M, Schepmoes AA, Fillmore TL, Sokoll LJ, Kronewitter SR, Izmirlian G, Shi T, Qian WJ, Leach RJ, Thompson IM, Chan DW, Smith RD, Kagan J, Srivastava S, Rodland KD, Camp DG 2nd. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests. J Proteomics 2012;75:4747-57. [PMID: 22846433 DOI: 10.1016/j.jprot.2012.01.035] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
31 Passerini R, Cassatella MC, Boveri S, Salvatici M, Radice D, Zorzino L, Galli C, Sandri MT. The pitfalls of CA19-9: routine testing and comparison of two automated immunoassays in a reference oncology center. Am J Clin Pathol 2012;138:281-7. [PMID: 22904141 DOI: 10.1309/AJCPOPNPLLCYR07H] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
32 Jin X, Cai C, Qiu Y. Diagnostic Value of Circulating microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. J Cancer. 2019;10:4754-4764. [PMID: 31598147 DOI: 10.7150/jca.32833] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
33 Uen YH, Lin KY, Sun DP, Liao CC, Hsieh MS, Huang YK, Chen YW, Huang PH, Chen WJ, Tai CC. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer. J Proteomics. 2013;83:197-213. [PMID: 23541716 DOI: 10.1016/j.jprot.2013.03.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
34 Yoshida M, Takimoto R, Murase K, Sato Y, Hirakawa M, Tamura F, Sato T, Iyama S, Osuga T, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J. Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach. PLoS One 2012;7:e39545. [PMID: 22808043 DOI: 10.1371/journal.pone.0039545] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
35 Slotta JE, Kollmar O, Ellenrieder V, Ghadimi BM, Homayounfar K. Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives. World J Hepatol 2015; 7(9): 1168-1183 [PMID: 26019733 DOI: 10.4254/wjh.v7.i9.1168] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
36 Reiter MJ, Costello JE, Schwope RB, Lisanti CJ, Osswald MB. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation. J Comput Assist Tomogr 2015;39:825-34. [PMID: 26248153 DOI: 10.1097/RCT.0000000000000297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
37 Chang C, Chen J, Huang CH, Lee WY, Hsu LC, Chiang AJ. Time-Dependent Squamous Cell Carcinoma Antigen in Prediction of Relapse and Death of Patients With Cervical Cancer. J Low Genit Tract Dis 2020;24:38-42. [PMID: 31860573 DOI: 10.1097/LGT.0000000000000499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
38 Wei Q, Wang C, Zhou X, Wu T, Wang Y, Li C, Yang N. Ionic liquid and spatially confined gold nanoparticles enhanced photoelectrochemical response of zinc-metal organic frameworks and immunosensing squamous cell carcinoma antigen. Biosensors and Bioelectronics 2019;142:111540. [DOI: 10.1016/j.bios.2019.111540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
39 Duffy MJ. Use of Biomarkers in Screening for Cancer. Adv Exp Med Biol 2015;867:27-39. [PMID: 26530358 DOI: 10.1007/978-94-017-7215-0_3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
40 Kamada M, Koshikawa N, Minegishi T, Kawada C, Karashima T, Shuin T, Seiki M. Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma. Cancer Sci 2015;106:1730-7. [PMID: 26450632 DOI: 10.1111/cas.12832] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
41 Zhou G, Chen X, Tang F, Zhou J, Wang Y, Wang Z. The Value of Diffusion-Weighted Imaging in Predicting the Prognosis of Stage IB-IIA Cervical Squamous Cell Carcinoma After Radical Hysterectomy. Int J Gynecol Cancer. 2016;26:361-366. [PMID: 26807567 DOI: 10.1097/igc.0000000000000613] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
42 Shen H, Guo M, Wang L, Cui X. MUC16 facilitates cervical cancer progression via JAK2/STAT3 phosphorylation-mediated cyclooxygenase-2 expression. Genes Genomics 2020;42:127-33. [PMID: 31736008 DOI: 10.1007/s13258-019-00885-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
43 Morota K, Komori M, Fujinami R, Yamada K, Kuribayashi K, Watanabe N, Sokoll LJ, Elliott D, Chan DW, Martens F, Heijboer AC, Blankenstein MA, Hershberger SJ, Pfeiffer ZA, Vaidya SV, Dowell BL. Improvement and multicenter evaluation of the analytical performance of an automated chemiluminescent immunoassay for alpha fetoprotein. Int J Biol Markers 2012;27:39-46. [PMID: 22020369 DOI: 10.5301/JBM.2011.8738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
44 Blanco-Calvo M, Tarrío N, Reboredo M, Haz-Conde M, García J, Quindós M, Figueroa A, Antón-Aparicio L, Calvo L, Valladares-Ayerbes M. Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer. Future Oncol. 2014;10:1187-1202. [PMID: 24947260 DOI: 10.2217/fon.13.263] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
45 Chen S, Feng XY, Li YF, Zhao BW, Zhou ZW, Chen YB. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy. J Surg Oncol. 2013;107:641-645. [PMID: 23297055 DOI: 10.1002/jso.23300] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
46 Zhao Z, Fan J, Hsu YS, Lyon CJ, Ning B, Hu TY. Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application. Lab Chip 2019;19:1114-40. [PMID: 30882822 DOI: 10.1039/c8lc01123k] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 18.0] [Reference Citation Analysis]
47 Tang Z, Ma Z. Multiple functional strategies for amplifying sensitivity of amperometric immunoassay for tumor markers: A review. Biosensors and Bioelectronics 2017;98:100-12. [DOI: 10.1016/j.bios.2017.06.041] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 13.0] [Reference Citation Analysis]
48 Zhang H, Ding R, Chen D. Value of miR-21 levels as potential biomarkers in the early diagnosis of hepatocellular carcinoma:a meta-analysis. Biomarkers 2021;:1-12. [PMID: 34266326 DOI: 10.1080/1354750X.2021.1955976] [Reference Citation Analysis]
49 Xiao J, He X, Wang Z, Hu J, Sun F, Qi F, Yang S, Xiao Z. Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer. Tumour Biol 2014;35:1331-4. [PMID: 24234331 DOI: 10.1007/s13277-013-1177-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ding Y, Yan JL, Fang AN, Zhou WF, Huang L. Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles. Oncotarget. 2017;8:66402-66413. [PMID: 29029522 DOI: 10.18632/oncotarget.18949] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
51 Yodmongkol S, Sutapun B, Praphanphoj V, Srikhirin T, Brandstetter T, Rühe J. Fabrication of protein microarrays for alpha fetoprotein detection by using a rapid photo-immobilization process. Sensing and Bio-Sensing Research 2016;7:95-9. [DOI: 10.1016/j.sbsr.2016.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
52 Salazar A, Zavala K. [Twin brothers, same reason for consulting, different days]. Semergen 2016;42:420-2. [PMID: 26277057 DOI: 10.1016/j.semerg.2015.06.018] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Sandri MT, Salvatici M, Mauro C, Radice D, Lentati P, Massaro MA, Boveri S, Zorzino L, Landoni F. Detection of Squamous Cell Carcinoma Antigen with Two Systems in the follow-up of Patients with Cervical Cancer. Int J Biol Markers 2013;28:313-7. [DOI: 10.5301/jbm.5000031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 de Rancher MR, Oudart JB, Maquart FX, Monboisse JC, Ramont L. Evaluation of Lumipulse® G1200 for the measurement of six tumor markers: Comparison with AIA® 2000. Clin Biochem 2016;49:1302-6. [PMID: 27521619 DOI: 10.1016/j.clinbiochem.2016.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
55 Du J, Hong J, Xu C, Cai Y, Xiang B, Zhou C, Xu X. Screening and Identification of ssDNA Aptamer for Human GP73. Biomed Res Int 2015;2015:610281. [PMID: 26583119 DOI: 10.1155/2015/610281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
56 Holdenrieder S, Molina R, Qiu L, Zhi X, Rutz S, Engel C, Kasper-sauer P, Dayyani F, Korse CM. Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer. Tumour Biol 2018;40:101042831877220. [DOI: 10.1177/1010428318772202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Docta RY, Ferronha T, Sanderson JP, Weissensteiner T, Pope GR, Bennett AD, Pumphrey NJ, Ferjentsik Z, Quinn LL, Wiedermann GE, Anderson VE, Saini M, Maroto M, Norry E, Gerry AB. Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive Liver Cancer. Hepatology. 2019;69:2061-2075. [PMID: 30561769 DOI: 10.1002/hep.30477] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
58 Shahangian S, Alspach TD, Astles JR, Yesupriya A, Dettwyler WK. Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010. Arch Pathol Lab Med 2014;138:189-203. [PMID: 23738761 DOI: 10.5858/arpa.2013-0149-OA] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
59 Chang C, Tai C, Su T, Shen K, Lin S, Yeh C, Yeh K, Lin Y, Jiang M. The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas. Annals of Diagnostic Pathology 2012;16:362-8. [DOI: 10.1016/j.anndiagpath.2012.02.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
60 Wang FB, Rong Y, Fang M, Yuan JP, Peng CW, Liu SP, Li Y. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles. Biomaterials 2013;34:3816-27. [PMID: 23465488 DOI: 10.1016/j.biomaterials.2013.02.018] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
61 Yamada HY, Zhang Y, Reddy A, Mohammed A, Lightfoot S, Dai W, Rao CV. Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice. Carcinogenesis. 2015;36:429-440. [PMID: 25740822 DOI: 10.1093/carcin/bgv011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
62 Torres C, Perales S, Alejandre MJ, Iglesias J, Palomino RJ, Martin M, Caba O, Prados JC, Aránega A, Delgado JR, Irigoyen A, Ortuño FM, Rojas I, Linares A. Serum cytokine profile in patients with pancreatic cancer. Pancreas 2014;43:1042-9. [PMID: 24979617 DOI: 10.1097/MPA.0000000000000155] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
63 Zhang W, Ou J, Lei F, Hou T, Wu S, Niu C, Xu L, Zhang Y. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer. Tumour Biol 2016;37:369-79. [PMID: 26219895 DOI: 10.1007/s13277-015-3806-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
64 op den Winkel M, Nagel D, Sappl J, op den Winkel P, Lamerz R, Zech CJ, Straub G, Nickel T, Rentsch M, Stieber P. Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort. PLoS One. 2012;7:e45066. [PMID: 23071507 DOI: 10.1371/journal.pone.0045066] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
65 Stenman UH. Validating serum markers for monitoring of cancer. Clin Chem 2013;59:4-5. [PMID: 23115053 DOI: 10.1373/clinchem.2012.195222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
66 Ganief T, Calder B, Blackburn JM. Protocols for Preparation and Mass Spectrometry Analysis of Clinical Urine Samples to Identify Candidate Biomarkers of Schistosoma-Associated Bladder Cancer. Methods Mol Biol 2021;2292:143-50. [PMID: 33651359 DOI: 10.1007/978-1-0716-1354-2_13] [Reference Citation Analysis]
67 Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M, Santamarina I, Blanco M, Fernández-Tajes J, Quindós M, Carral A, Figueroa A, Antón-Aparicio LM, Calvo L. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 2012;10:186. [PMID: 22954417 DOI: 10.1186/1479-5876-10-186] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 10.6] [Reference Citation Analysis]
68 Lamerz R. Are Biomarkers Still Helpful in Hepatocellular Carcinoma? Digestion 2013;87:118-20. [DOI: 10.1159/000346282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Balabanova L, Golotin V, Kovalchuk S, Bulgakov A, Likhatskaya G, Son O, Rasskazov V. A novel bifunctional hybrid with marine bacterium alkaline phosphatase and Far Eastern holothurian mannan-binding lectin activities. PLoS One 2014;9:e112729. [PMID: 25397876 DOI: 10.1371/journal.pone.0112729] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
70 Chen M, Wu Y, Lin G, Hou J, Li M, Liu T. Quantum-dot-based homogeneous time-resolved fluoroimmunoassay of alpha-fetoprotein. Analytica Chimica Acta 2012;741:100-5. [DOI: 10.1016/j.aca.2012.06.042] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
71 Kumar A, Acharya SK, Singh SP, Saraswat VA, Arora A, Duseja A, Goenka MK, Jain D, Kar P, Kumar M, Kumaran V, Mohandas KM, Panda D, Paul SB, Ramachandran J, Ramesh H, Rao PN, Shah SR, Sharma H, Thandassery RB; (The INASL Task-Force on Hepatocellular Carcinoma). The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations. J Clin Exp Hepatol 2014;4:S3-S26. [PMID: 25755608 DOI: 10.1016/j.jceh.2014.04.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
72 Yu H, Luo Y, Wang X, Bai L, Huang P, Wang L, Huang M, Deng Y, Wang J. Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer. Sci Rep 2016;6:34131. [PMID: 27658525 DOI: 10.1038/srep34131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
73 Geng J, Fan J, Wang Q, Zhang XP, Kang L, Li QY, Xu YF, Peng B, Zheng JH, Yao XD. Decreased REG1α expression suppresses growth, invasion and angiogenesis of bladder cancer. Eur J Surg Oncol 2017;43:837-46. [PMID: 28209239 DOI: 10.1016/j.ejso.2017.01.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
74 Zhang XY, Ma H, Li J, Lu XR, Li JQ, Yuan N, Zhang ZL, Xue XY. Functional implications of miR-145/RCAN3 axis in the progression of cervical cancer. Reprod Biol 2020;20:140-6. [PMID: 32345470 DOI: 10.1016/j.repbio.2020.04.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Hu Z, Zhao W. Novel insights into the molecular mechanisms of α-fetoprotein expression and malignant phenotypes of hepatocellular carcinoma. Cell Mol Immunol 2012;9:7-8. [PMID: 21860406 DOI: 10.1038/cmi.2011.30] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
76 Cheng D, Liang B, Li Y. Clinical value of vascular endothelial growth factor and endostatin in urine for diagnosis of bladder cancer. Tumori 2012;98:762-7. [DOI: 10.1177/030089161209800614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
77 Crujeiras AB, Díaz-Lagares A, Abete I, Goyenechea E, Amil M, Martínez JA, Casanueva FF. Pre-treatment circulating leptin/ghrelin ratio as a non-invasive marker to identify patients likely to regain the lost weight after an energy restriction treatment. J Endocrinol Invest 2014;37:119-26. [PMID: 24497210 DOI: 10.1007/s40618-013-0004-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
78 Liu CG, Cui XL, Wei ZG, Guo JS. High expression of the ANKRD49 protein is associated with progression and poor prognosis of gastric cancer. Cancer Biomark 2018;22:649-56. [PMID: 29865034 DOI: 10.3233/CBM-171074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
79 Arpalahti L, Laitinen A, Hagström J, Mustonen H, Kokkola A, Böckelman C, Haglund C, Holmberg CI. Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis. PLoS One 2018;13:e0193125. [PMID: 29474458 DOI: 10.1371/journal.pone.0193125] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
80 Yim M, Ha Y, Kim IY, Yun S, Choi YH, Kim W. HMOX1 is an Important Prognostic Indicator of Nonmuscle Invasive Bladder Cancer Recurrence and Progression. Journal of Urology 2011;185:701-5. [DOI: 10.1016/j.juro.2010.09.081] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
81 Yang X, Guo X, Chen Y, Chen G, Ma Y, Huang K, Zhang Y, Zhao Q, Winkler CA, An P. Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma. Oncotarget. 2016;7:27838-27847. [PMID: 27056898 DOI: 10.18632/oncotarget.8539] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
82 Larré S, Camparo P, Comperat E, Gil Diez De Medina S, Traxer O, Roupret M, Sebe P, Cancel-Tassin G, Sighar K, Lozach F. Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test. Eur Urol. 2011;59:250-257. [PMID: 21056532 DOI: 10.1016/j.eururo.2010.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
83 Ecke TH, Weiß S, Stephan C, Hallmann S, Arndt C, Barski D, Otto T, Gerullis H. UBC® Rapid Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study. Int J Mol Sci 2018;19:E3841. [PMID: 30513851 DOI: 10.3390/ijms19123841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
84 Ecke TH, Weiß S, Stephan C, Hallmann S, Barski D, Otto T, Gerullis H. UBC® Rapid Test for detection of carcinoma in situ for bladder cancer. Tumour Biol 2017;39:1010428317701624. [PMID: 28468590 DOI: 10.1177/1010428317701624] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
85 Duffy M, Harbeck N, Nap M, Molina R, Nicolini A, Senkus E, Cardoso F. Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM). European Journal of Cancer 2017;75:284-98. [DOI: 10.1016/j.ejca.2017.01.017] [Cited by in Crossref: 220] [Cited by in F6Publishing: 197] [Article Influence: 55.0] [Reference Citation Analysis]
86 Salvatici M, Achilarre MT, Sandri MT, Boveri S, Vanna Z, Landoni F. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence. Gynecol Oncol 2016;142:115-9. [PMID: 27117922 DOI: 10.1016/j.ygyno.2016.04.029] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
87 Zhou LL, Shen Y, Gong JM, Sun P, Sheng JH. MicroRNA-466 with tumor markers for cervical cancer screening. Oncotarget 2017;8:70821-7. [PMID: 29050322 DOI: 10.18632/oncotarget.19992] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
88 Crescenzi M, Tessari A, Biasiolo A, Padoan A, Gallotta A, Fassina G, Panciatichi C, Rossetto O, Pontisso P, Basso D, Plebani M. Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma. Anal Methods 2015;7:629-37. [DOI: 10.1039/c4ay02495h] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
89 Zheng W, Zhou S, Xu J, Liu Y, Huang P, Liu Y, Chen X. Ultrasensitive Luminescent In Vitro Detection for Tumor Markers Based on Inorganic Lanthanide Nano-Bioprobes. Adv Sci (Weinh) 2016;3:1600197. [PMID: 27980996 DOI: 10.1002/advs.201600197] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
90 Chambers AG, Percy AJ, Simon R, Borchers CH. MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum. Expert Rev Proteomics 2014;11:137-48. [PMID: 24476379 DOI: 10.1586/14789450.2014.877346] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 7.6] [Reference Citation Analysis]
91 Pilzweger C, Holdenrieder S. Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases. Diagnostics (Basel) 2015;5:219-53. [PMID: 26854151 DOI: 10.3390/diagnostics5020219] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
92 Liao Y, Tang H, Wang M, Wang K, Wang Y, Jiang N. The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta-analysis. J Clin Lab Anal 2021;35:e23765. [PMID: 33780049 DOI: 10.1002/jcla.23765] [Reference Citation Analysis]
93 Kočevar N, Odreman F, Vindigni A, Grazio SF, Komel R. Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers. World J Gastroenterol 2012; 18(11): 1216-1228 [PMID: 22468085 DOI: 10.3748/wjg.v18.i11.1216] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
94 Yang H, Chen G, Fang F, Liu Z, Hiu Yan Lau S, Zhang J, Lau WY, Yang L. Dickkopf-1: As a Diagnostic and Prognostic Serum Marker for Early Hepatocellular Carcinoma. Int J Biol Markers 2013;28:286-97. [DOI: 10.5301/jbm.5000015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
95 Worland T, Harrison B, Delmenico L, Dowling D. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis. J Gastrointest Cancer 2018;49:476-80. [PMID: 28920172 DOI: 10.1007/s12029-017-0006-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
96 Jo JC, Ryu MH, Koo DH, Ryoo BY, Kim HJ, Kim TW, Choi KD, Lee GH, Jung HY, Yook JH. Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer. Asia Pac J Clin Oncol. 2013;9:324-330. [PMID: 23176400 DOI: 10.1111/ajco.12019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
97 Fehm T, Banys M, Rack B, Jäger B, Hartkopf A, Taran FA, Janni W. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients. Int J Cancer 2014;134:925-31. [PMID: 23921989 DOI: 10.1002/ijc.28417] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
98 Wang C, Wu T, Wang X, Wei Q, Wang Y, Li C, Sun D. Ultrathin-layered carbon intercalated MoS2 hollow nanospheres integrated with gold nanoparticles for photoelectrochemical immunosensing of squamous cell carcinoma antigen. Sensors and Actuators B: Chemical 2019;297:126716. [DOI: 10.1016/j.snb.2019.126716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
99 He X, Li JP, Liu XH, Zhang JP, Zeng QY, Chen H, Chen SL. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors. J Cancer 2018;9:1877-84. [PMID: 29805715 DOI: 10.7150/jca.23320] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
100 Moţăţăianu A, Maier S, Gothard A, Bajkó Z, Bălaşa R. Severe Fatal Systemic Embolism Due to Non-Bacterial Thrombotic Endocarditis as the Initial Manifestation of Gastric Adenocarcinoma: Case Report. J Crit Care Med (Targu Mures) 2018;4:68-73. [PMID: 30581998 DOI: 10.2478/jccm-2018-0008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
101 Yang MY, Wu F, Fang F, Yang H, Zhang JF, Chen GD, Yang LY. Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma. BMC Cancer 2021;21:772. [PMID: 34217251 DOI: 10.1186/s12885-021-08491-3] [Reference Citation Analysis]
102 Chen J, Yao D, Li Y, Chen H, He C, Ding N, Lu Y, Ou T, Zhao S, Li L, Long F. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med 2013;32:557-67. [PMID: 23799609 DOI: 10.3892/ijmm.2013.1424] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 11.6] [Reference Citation Analysis]
103 Galle PR, Foerster F, Kudo M, Chan SL, Llovet JM, Qin S, Schelman WR, Chintharlapalli S, Abada PB, Sherman M, Zhu AX. Biology and significance of alpha-fetoprotein in hepatocellular carcinoma. Liver Int. 2019;39:2214-2229. [PMID: 31436873 DOI: 10.1111/liv.14223] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 30.0] [Reference Citation Analysis]
104 Galli C, Basso D, Plebani M. CA 19-9: handle with care. Clin Chem Lab Med. 2013;51:1369-1383. [PMID: 23370912 DOI: 10.1515/cclm-2012-0744] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 6.9] [Reference Citation Analysis]
105 Shimura T, Ebi M, Yamada T, Yamada T, Katano T, Nojiri Y, Iwasaki H, Nomura S, Hayashi N, Mori Y, Kataoka H, Moses MA, Joh T. Urinary kallikrein 10 predicts the incurability of gastric cancer. Oncotarget 2017;8:29247-57. [PMID: 28418926 DOI: 10.18632/oncotarget.16453] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
106 Osuga T, Takimoto R, Ono M, Hirakawa M, Yoshida M, Okagawa Y, Uemura N, Arihara Y, Sato Y, Tamura F, Sato T, Iyama S, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J. Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer. J Natl Cancer Inst 2016;108. [PMID: 27075853 DOI: 10.1093/jnci/djw038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
107 Chen Z, Zheng W, Huang P, Tu D, Zhou S, Huang M, Chen X. Lanthanide-doped luminescent nano-bioprobes for the detection of tumor markers. Nanoscale 2015;7:4274-90. [DOI: 10.1039/c4nr05697c] [Cited by in Crossref: 83] [Cited by in F6Publishing: 8] [Article Influence: 13.8] [Reference Citation Analysis]
108 Wan Q, Wang T, Zhang K. Biomedical optical spectroscopy for the early diagnosis of gastrointestinal neoplasms. Tumour Biol 2017;39:101042831771798. [DOI: 10.1177/1010428317717984] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
109 Jiang S, Liu H, Liu Z, Liu N, Liu R, Kang Y, Ji J, Zhang C, Hua B, Kang S. Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy. Chin J Integr Med 2017;23:331-7. [DOI: 10.1007/s11655-015-2146-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
110 Dolscheid-Pommerich RC, Keyver-Paik M, Hecking T, Kuhn W, Hartmann G, Stoffel-Wagner B, Holdenrieder S. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers. Tumour Biol 2017;39:1010428317730246. [PMID: 29034816 DOI: 10.1177/1010428317730246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
111 Pei F, Wang P, Ma E, Yang Q, Yu H, Liu J, Yin H, Li Y, Liu Q, Dong Y. A sensitive label-free immunosensor for alpha fetoprotein detection using platinum nanodendrites loaded on functional MoS2 hybridized polypyrrole nanotubes as signal amplifier. Journal of Electroanalytical Chemistry 2019;835:197-204. [DOI: 10.1016/j.jelechem.2019.01.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
112 Gupta S, Gupta K, Ravi R, Mehta V, Banerjee S, Joshi S, Saboo B. Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study. Indian J Endocrinol Metab 2015;19:639-43. [PMID: 26425474 DOI: 10.4103/2230-8210.163187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
113 Huang LP, Savoly D, Sidi AA, Adelson ME, Mordechai E, Trama JP. CIP2A protein expression in high-grade, high-stage bladder cancer. Cancer Med 2012;1:76-81. [PMID: 23342256 DOI: 10.1002/cam4.15] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
114 Sekiguchi M, Matsuda T. Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening. Sci Rep 2020;10:18202. [PMID: 33097814 DOI: 10.1038/s41598-020-75319-8] [Reference Citation Analysis]
115 Hermann N, Dressen K, Schroeder L, Debald M, Schildberg FA, Walgenbach-bruenagel G, Hettwer K, Uhlig S, Kuhn W, Hartmann G, Holdenrieder S. Diagnostic relevance of a novel multiplex immunoassay panel in breast cancer. Tumour Biol 2017;39:101042831771138. [DOI: 10.1177/1010428317711381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
116 Wang H, Lakshmipriya T, Chen Y, Gopinath SCB. Squamous Cell Carcinoma Biomarker Sensing on a Strontium Oxide-Modified Interdigitated Electrode Surface for the Diagnosis of Cervical Cancer. Biomed Res Int 2019;2019:2807123. [PMID: 31080815 DOI: 10.1155/2019/2807123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
117 Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H, Xiao B, Xia T, Yu X, Le Y. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer. 2013;119:1618-1626. [PMID: 23335180 DOI: 10.1002/cncr.27903] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 11.5] [Reference Citation Analysis]
118 Ye X, Li M, Hu Y, Wang Z, Wang Y, Deng H, Xiong X, Li C, Sun D. Sensitive photoelectrochemical immunosensor for squamous cell carcinoma antigen based on MoSe2 nanosheets and hollow gold nanospheres. Sensors and Actuators B: Chemical 2018;275:199-205. [DOI: 10.1016/j.snb.2018.08.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
119 Xu D, Wang D, Wang S, Tian Y, Long Z, Ren X. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis. Int J Gynecol Cancer 2017;27:1935-42. [PMID: 28914639 DOI: 10.1097/IGC.0000000000001112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]